PrednisoloneMyasthenia Gravis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1932卷 / 1期

关键词：

D O I：

10.1007/s40278-022-27870-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：505 / 505

相关论文

共 50 条

[1] Ciprofloxacin/prednisoloneMyasthenia gravis leading to bulbar paresis and subsequently respiratory insufficiency: case report
Reactions Weekly, 2016, 1584 (1) : 60 - 60
[2] PembrolizumabMyasthenia gravis: case report
Reactions Weekly, 2018, 1694 (1) : 353 - 353
[3] NivolumabMyasthenia gravis: case report
Reactions Weekly, 2019, 1774 (1) : 241 - 241
[4] SotalolMyasthenia gravis: case report
Reactions Weekly, 2019, 1778 (1) : 421 - 421
[5] NivolumabMyasthaenia gravis: case report
Reactions Weekly, 2019, 1773 (1) : 257 - 257
[6] RegorafenibMyasthenia gravis: case report
Reactions Weekly, 2023, 1953 (1) : 350 - 350
[7] PenicillamineMyasthenia gravis: case report
Reactions Weekly, 2012, 1424 (1) : 41 - 41
[8] HydroxychloroquineMyasthenia gravis: case report
Reactions Weekly, 2019, 1737 (1) : 152 - 152
[9] PembrolizumabMyasthenia gravis: case report
Reactions Weekly, 2019, 1776 (1) : 364 - 364
[10] TislelizumabMyasthenia gravis: case report
Reactions Weekly, 2024, 2025 (1) : 437 - 437

← 1 2 3 4 5 →